When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...

Scientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Lipid nanoparticles have emerged as critical platforms for drug and gene delivery, with the success of mRNA COVID-19 vaccines highlighting their potential.

Utrecht University researchers Bas van Ravensteijn and Markus Weingarth have each been awarded an ERC Proof of Concept Grant of €150.000 to further enhance antibiotics and nanomedice ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...